Navigation Links
Boston Scientific Closes Cameron Health Acquisition
Date:6/8/2012

       

At the recent Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston, Cameron Health announced initial results from the international "Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS (EFFORTLESS) Subcutaneous Implantable Defibrillator Registry" study that showed the S-ICD System is performing appropriately in real-world circumstances and continues to demonstrate positive results in a study of 230 patients.  Cameron Health also announced at the conference that the S-ICD System met the primary safety and efficacy endpoints defined in their 330-patient IDE clinical study.  The patient population in the IDE study patient population closely mirrored real world populations with transvenous ICDs, demonstrating that the S-ICD System is an important new treatment option for a wide range of primary and secondary prevention patients.  In addition, the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel recommended approval of the S-ICD System in April of 2012.  FDA approval is expected in the first half of 2013.  The S-ICD System received CE Mark in 2009 and is commercially available in many countries in Europe, as well as New Zealand.  To date, more than 1,300 devices have been implanted in patients around the world.

In countries where it is approved, the S-ICD System establishes a new class of protection from sudden cardiac arrest that offers physicians more options in how to best treat their patients.  While it provides the same defibrillation protection of transvenous ICDs, the S-ICD System also preserves the patient's venous system, which may be advantageous to many patients. 

Transaction Details

The transaction follows Boston Scientific's exercise of its option to acquire Cameron Health announced on March 8, 2012. Under the terms of the agreement, Boston Scientific paid $150 million at closing. 
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medical Device Developers - Network at BIOMEDevice Boston Next Week
2. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
3. Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering
4. Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
5. One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
6. Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent
7. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
8. Clean Room Environmental Best Practices for Medical Device & Pharmaceutical Manufacturers are Focus of Boston Seminar on June 6
9. Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
10. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
11. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Grifols, a global healthcare company based in ... a study demonstrating that a higher dose of PROLASTIN ... of the alpha 1 protein in patients with ... considered within the normal range for healthy individuals. AAT ... levels of the alpha 1 proteinase inhibitor (A1PI) ...
(Date:5/22/2013)... May 22, 2013 Varian Medical Systems ... received 510(k) clearance from the U.S. Food and ... processing workstation that combines radio frequency (RF) and ... Nexus DRF Digital X-Ray Imaging System™ has the ... receptors, including CCD cameras and commercially available flat-panel ...
(Date:5/22/2013)... While many parents may think that allowing ... home under adult supervision keeps kids safe and leads ... there are serious negative consequences for both parents and ... The Treatment Research Institute (TRI) today announced the ... and caregivers to help inform them about one of ...
Breaking Medicine Technology:Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 3Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 4Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 5Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 6Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 7
... June 28, 2011 The Mirixa Corporation and ... are pleased to announce that MirixaPro(SM), a Web-based ... patient care service delivery, will be deployed in ... agreement enabling CACDS to use a scalable, localized ...
... 2011 ,   The ... range of,new clinical data. The "Late-Breaking Clinical Trials" were ... SHPT study,(Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet,With ... June the,principal investigator of this study, Prof. Markus Ketteler,(Coburg, ...
Cached Medicine Technology:Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 2Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 3Update on IMPACT Study Results 2
(Date:5/22/2013)... leader, Professor John Mathews from the University of Melbourne ... weighed against the undoubted benefits from CT scans in ... reported in the British Medical Journal today ... Oxford University, and the International Agency for Research on ... "CT scans were very useful in providing detailed three ...
(Date:5/22/2013)... percent of patients being treated for COPD at ... disease, researchers found after evaluating the patients with ... pulmonary disease. , "While there have been many ... not been a U.S.-based study that has quantified ... MSc, a second-year medical resident at Saint ...
(Date:5/22/2013)... The PreDiabetes Center of King ... Greater Philadelphia Tour de Cure, a premier cycling event that ... about stopping the spread of diabetes , a chronic ... The Tour de Cure will take place Saturday, June 1 ... Ambler, 30 minutes outside of Philadelphia, between the hours of ...
(Date:5/22/2013)... Detroit, Michigan (PRWEB) May 22, 2013 ... free service filters through local businesses and connects consumers ... seconds. Detroit’s residents have less time to handle personal ... their longer commutes to and from work. So, they ... searching for the right local available professional. , Now, ...
(Date:5/22/2013)... 22, 2013 CoCENTRIX, a leading ... Health and Human Services and community providers, announced ... (ADMH) selected the CoCENTRIX Coordinated Care Platform ... the Health Records and coordinate care within and ... , CoCENTRIX is transitioning the hospitals' official records ...
Breaking Medicine News(10 mins):Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:Study finds COPD is over-diagnosed among uninsured patients 2Health News:Study finds COPD is over-diagnosed among uninsured patients 3Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 3
... HealthDay Reporter , TUESDAY, May 15 (HealthDay News) -- ... works well in adolescents, new research indicates. Although ... "it is nice to have this officially shown in ... director of neurology at Maimonides Medical Center in New ...
... acid taken up to three times their recommended daily ... higher levels as some supplement manufacturers suggest, these three supplements ... a host of cancers. , "It,s not that these nutrients ... we need them in a certain balance," says Tim Byers, ...
... suggests that specific populations of tumor cells have different roles ... themselves and grow. In their report in the May ... tumor-propagating cell required for the growth of a pediatric muscle ... more-differentiated tumor cell must first travel to sites of new ...
... June,s Journal of Thoracic Oncology says molecular biomarkers ... an additional predictive technique for lung cancer screening. , ... of the positive CT screening results were false positive, scientists ... This research focused on a way to determine if the ...
... (SACRAMENTO, Calif.) A vaccine that targets cancer cells in ... breast cancer, significantly increased survival when tested in mice, a ... findings will be published today in the journal Clinical ... and the hormonal drug letrozole were more effective when given ...
... 15 (HealthDay News) -- Patient education and medication compliance contributed ... with life-threatening asthma admitted to the intensive care unit at ... review of 30 years of hospital data focused on patients ... They found that there were 227 patients admitted to the ...
Cached Medicine News:Health News:Two-Drug Combo Helps Teens With Migraines 2Health News:All cancer cells are not created equal 2Health News:All cancer cells are not created equal 3Health News:Cancer vaccine combination therapy shows survival benefit in breast cancer 2Health News:Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study 2
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
... and ristocetin cofactor testing, couples a ... Windows-based software for unsurpassed testing flexibility. ... can be run on one Remote ... configure your analyzers to suite your ...
... Model 700 Whole Blood/Optical Lumi-Aggregometer available in ... new Aggregometer measures platelet function on patient ... or optical density in plasma with simultaneously ... The Model 700 Aggregometer also has the ...
Medicine Products: